LUNA Surges 20% in a Day Amid Ongoing Terra Network Upgrade
- LUNA surged 20% in 24 hours to $0.0868 as Terra network prepares a major upgrade on Dec 8, 2025. - Binance temporarily halted LUNA deposits/withdrawals during the upgrade to ensure protocol stability. - Adverum Biotech reported 90% reduced anti-VEGF injections in LUNA trial for wet AMD, with Phase 3 enrollment nearing completion. - The upgrade and biotech results highlight LUNA's dual impact on crypto markets and medical innovation potential.
LUNA Sees Notable Price Surge
On December 5, 2025, LUNA experienced a sharp 20% increase in value within a single day, reaching $0.0868. Over the past week, the token climbed by 22.99%, maintaining the same growth rate over the past month. However, LUNA has declined by 78.59% over the previous year.
Upcoming Terra Network Upgrade
The Terra blockchain is scheduled for a significant protocol upgrade on December 8, 2025, at block height 18,660,000. To facilitate a smooth transition, Binance will temporarily suspend deposits and withdrawals for LUNA (Terra) starting at 20:05 UTC+8 on the day of the upgrade. The process is anticipated to conclude by approximately 21:05 UTC+8.
This temporary suspension is a routine measure during major blockchain updates to minimize transaction disruptions. Users are encouraged to follow Binance’s official channels for timely updates and notifications regarding the resumption of services.
Adverum Biotechnologies Shares Promising LUNA Trial Results
In a separate development, Adverum Biotechnologies, Inc. announced two-year follow-up data from its LUNA Phase 2 trial of Ixo-vec for patients with wet age-related macular degeneration (AMD) on December 4, 2025. The results revealed an approximate 90% decrease in the need for anti-VEGF injections over two years, while maintaining both anatomical stability and visual acuity across both dosage groups. Notably, the 6E10 dose group reported no new cases of inflammation after week 30. Ixo-vec continues to show a strong safety record.
These positive outcomes support the continued advancement of the therapy, with the Phase 3 ARTEMIS trial expected to complete enrollment by December 5, 2025. Adverum has highlighted Ixo-vec’s potential to revolutionize wet AMD treatment by reducing injection frequency compared to existing therapies.
Summary
LUNA’s recent price rally, the forthcoming Terra network upgrade, and encouraging clinical results from Adverum Biotechnologies are all pivotal factors influencing current market sentiment. The network update is expected to strengthen the blockchain’s long-term resilience, while the biotech company’s progress may enhance the LUNA brand’s reputation beyond the cryptocurrency industry.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Solana's Latest Price Drop: Analyzing Systemic Vulnerabilities in Advanced Blockchain Platforms
- Solana's 2025 price drop and declining user activity, despite strong on-chain metrics, highlight systemic risks in high-performance blockchains. - Network Value to Transaction (NVT) ratio spikes and macroeconomic headwinds exposed vulnerabilities in consensus mechanisms and validator centralization. - Security breaches, regulatory uncertainties, and cross-chain bridge risks amplified downward pressure, contrasting with whale accumulation and real-world asset adoption growth. - Case studies of Avalanche a
SOL Price Forecast for 2025: Can the Altcoin Surge Last?
- Solana (SOL) gains traction in 2025 through institutional partnerships and ETFs, boosting blockchain adoption. - Despite $101.7M ETF inflows, SOL prices fell 30% by December, highlighting macroeconomic pressures over institutional demand. - Proposed inflation reduction (SIMD-0411) and short-term rallies signal resilience, but Bitcoin/Ethereum dominance complicates altcoin sustainability. - Analysts project $400–$500 SOL by year-end, contingent on resolving rate volatility and global economic uncertaintie
The BTC Collapse: Examining the Triggers and Consequences for 2026
- Bitcoin's 2026 collapse risk stems from leverage, quantum threats, and macroeconomic fragility, mirroring 2008/1929 crises. - Leverage-driven liquidation loops and corporate Bitcoin holdings create self-fulfilling price cascades across crypto and traditional markets. - Quantum computing could break Bitcoin's cryptography, while regulatory uncertainty amplifies systemic risks in its financialized ecosystem. - Historical parallels highlight recurring patterns of speculative excess and leverage, urging robu
The Bitcoin Leverage Liquidation Dilemma: How Investor Actions and Systemic Threats Shape a Financialized Cryptocurrency Market
- October 2025's Bitcoin futures liquidation wiped $19B, exposing systemic risks from leveraged crypto exposure. - Herd mentality and ultra-leveraged products (3x/5x ETFs) amplified volatility, triggering cascading liquidations during price drops. - SEC restricted 2x leverage caps but overlooked stablecoin risks and opaque crypto-lending structures fueling contagion. - Regulators now face balancing innovation with systemic safeguards, including stress-testing crypto-linked institutions and enforcing stable
Trending news
MoreCrypto prices
More
